Clindamycin Blood Agar (CBA) is an enriched selective media used for the isolation and presumptive identification of Eikenella corrodens.
Clindamycin Blood Agar – CBA
Product Description & Summary
CBA is a tryptic soy agar base supplemented with clindamycin at a concentration that inhibits most gram-positive and gram-negative anaerobes, with some exceptions. This media is prepared, stored, and dispensed under oxygen-free conditions to prevent the formation of oxidized products prior to use.
Interpretation of Results & Limitations
If used properly, CBA will support good growth of Eikenella corrodens found in clinical infections.
CBA will not provide complete information for identification of bacterial isolates. Additional test procedures and media are required for complete identification. It is recommended that a non-selective media, such as Brucella Blood Agar (BRU, catalog #: AS-111) also be inoculated from the same clinical specimen to assure recovery of all species present. Consult reference
The following organisms are routinely used for quality control testing at Anaerobe Systems.
|Organism Tested||ATCC #||Results||Time|
|Eikenella corrodens||23834||Growth||24 – 48 hrs|
|Escherichia coli||25922||Growth||24 hrs|
|Peptostreptococcus anaerobius||27337||No Growth|
|Fusobacterium nucleatum||25586||No Growth|
|Bacteroides fragilis||25285||No Growth|
|Prevotella melaninogenica||25845||No Growth|
|Propionibacterium acnes||6919||No Growth|
|Enterococcus faecalis||29212||Growth||24 hrs|
Product Storage & Shelf Life
Storage: Upon receipt, store at room temperature in original package until used. Avoid overheating or freezing. Do not use media if there are signs of deterioration (shrinking, cracking, or discoloration due to oxidation of media) or contamination. The expiration date applies to the product in its original packaging and stored as directed. Do not use product past the expiration date shown on the label.
Shelf Life: 90 days from date of manufacture.